Sciclones Overallotment Option Fully Exercised As Stock Stabilizes
Edge Medical-B (02675) announced the full exercise of the over-allotment option and the end of the price stabilization period. The lead underwriter did not intervene in the market. The additional H shares issued were primarily used to deliver shares to international investors who experienced delays in receiving them. This action signifies the completion of the company's stock issuance and price stabilization measures.









